Skeletal muscle-targeted peptide MSP
Ref. 3D-CRB1001632
| 1mg | 271.00 € | ||
| 500µg | 198.00 € |
Product Information
- H-ASSLNIA-OH
Gene therapy is potentially an ideal treatment for muscle tissue myopathies but targeting remains an issue. The large volume of muscle in the body versus the requirement for tissue-specificity is of particular concern. This heptapeptide has been shown to preferentially bind skeletal myofibers and thus can be used to study targeting of peptide/gene-delivery to muscle tissue. Research into gene therapy of Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA) has been of particular interest with muscle targeting peptides. This product already shows ideal placement to continue that research to overcome some of these issues.
Chemical properties
Technical inquiry about: 3D-CRB1001632 Skeletal muscle-targeted peptide MSP
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
